NASDAQ:VERU

Veru News Headlines

$13.38

-0.91 (-6.37%)

(As of 05/20/2022 04:00 PM ET)

Add

Compare

Today's Range: $12.66
▼
$14.21
50-Day Range: $4.35
▼
$15.60
52-Week Range: $4.34
▼
$17.50

Volume: 11.55 million shs
Average Volume: 24.79 million shs
Market Capitalization: $1.07 billion

P/E Ratio: N/A
Dividend Yield: N/A
Beta: -0.57

Get Veru News Delivered to You Automatically

Media Mentions By Week

Veru Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

VERU
News Sentiment
▼
0.18

0.30
▲
Average
Medical
News Sentiment

Media Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

VERU Articles
This Week
▼
29

6
▲
VERU Articles
Average Week

Veru (NASDAQ:VERU) News Headlines Today

Source

Source	Headline
	Brookline Capital Acquisition Increases Veru (NASDAQ:VERU) Price Target to $31.00 marketbeat.com - May 18 at 3:11 PM
	Brookline Capital Management Increases Veru (NASDAQ:VERU) Price Target to $31.00 americanbankingnews.com - May 20 at 5:25 AM
	Veru (NASDAQ:VERU) Shares Gap Up After Analyst Upgrade americanbankingnews.com - May 20 at 4:28 AM
	Veru (NASDAQ:VERU) PT Raised to $31.00 at Brookline Capital Acquisition americanbankingnews.com - May 20 at 3:49 AM
	Veru To Present At H.C. Wainwright Global Investment Conference On May 24th 2022 - Benzinga - Benzinga benzinga.com - May 19 at 9:58 AM
	Catch Fast-Moving Veru Stock as Covid-19 Drug Results Show Promise - Nasdaq nasdaq.com - May 19 at 4:51 AM
	Veru Inc. Still Has Serious Growth To Realize - Seeking Alpha seekingalpha.com - May 19 at 4:51 AM
	Veru to Present at the HC Wainwright Global Investment Conference on May 24th 2022 - GlobeNewswire globenewswire.com - May 18 at 11:51 PM
	Veru Announces Appointment of Joel Batten to Lead U.S. Infectious Disease Franchise to Focus on Hospitalized COVID-19 Patients - Yahoo Finance finance.yahoo.com - May 18 at 6:50 PM
	Veru Announces Appointment of Joel Batten to Lead U.S. Infectious Disease Franchise to Focus on Hospitalized COVID-19 Patients finance.yahoo.com - May 18 at 6:50 PM
	VERU Stock Alert: 6 Things to Know as Veru Appoints a New Executive investorplace.com - May 18 at 11:02 AM

	So What's Up With Veru Shares Rising Today? - Benzinga - Benzinga benzinga.com - May 18 at 2:55 AM
	Catch Fast-Moving Veru Stock as Covid-19 Drug Results Show Promise - InvestorPlace investorplace.com - May 17 at 4:54 PM
	Veru: Where Big Pharma Failed To Tread - Seeking Alpha seekingalpha.com - May 17 at 4:54 PM
	Catch Fast-Moving Veru Stock as Covid-19 Drug Results Show Promise investorplace.com - May 17 at 1:02 PM
	Veru to Present at the H.C. Wainwright Global Investment Conference on May 24th 2022 - Yahoo Finance finance.yahoo.com - May 17 at 9:01 AM
	Veru to Present at the H.C. Wainwright Global Investment Conference on May 24th 2022 finance.yahoo.com - May 17 at 9:01 AM
	Veru (NASDAQ:VERU) Price Target Raised to $55.00 at Jefferies Financial Group americanbankingnews.com - May 17 at 2:11 AM
	How Is The Market Feeling About Veru? - Benzinga - Benzinga benzinga.com - May 16 at 6:00 PM
	Veru: EUA for Covid-19 Treatment Could Be Granted by Q3, Says Oppenheimer finance.yahoo.com - May 16 at 6:00 PM
	Thinking about buying stock in Borr Drilling, Desktop Metal, Veru, Unity Software, or Redbox Entertainmen - Benzinga benzinga.com - May 15 at 12:18 PM
	Veru (NASDAQ:VERU) Rating Reiterated by Cantor Fitzgerald americanbankingnews.com - May 15 at 1:34 AM
	Veru Shares Spike, Jefferies Reiterates Buy Rating And Raises PT To $55 - Benzinga - Benzinga benzinga.com - May 13 at 2:27 PM
	BioMed Stocks On the Move: Nova Mentis, PolarityTE, Veru, and PharmaDrug; Life Sciences Leaders Report Latest Advances in Regenerative Tissue Technology, Novel Therapeutics for Oncology, COVID, Glaucoma, and Autism - GlobeNewswire globenewswire.com - May 13 at 2:27 PM
	VERU stock surges as Jefferies raises target citing COVID-19 candidate (NASDAQ:VERU) - Seeking Alpha seekingalpha.com - May 13 at 2:27 PM
	BioMed Stocks On the Move: Nova Mentis, PolarityTE, Veru, and PharmaDrug; Life Sciences Leaders Report Latest Advances in Regenerative Tissue Technology, Novel Therapeutics for Oncology, COVID, Glaucoma, and Autism finance.yahoo.com - May 13 at 2:27 PM
	Veru (NASDAQ:VERU) Has Debt But No Earnings; Should You Worry? finance.yahoo.com - May 13 at 2:27 PM
	Veru Inc.'s (VERU) CEO Mitchell Steiner on Q2 2022 Results - Earnings Call Transcript - Seeking Alpha seekingalpha.com - May 13 at 2:49 AM
	Veru GAAP EPS of -$0.18 misses by $0.06, revenue of $13.03M misses by $2.23M (NASDAQ:VERU) - Seeking Alpha seekingalpha.com - May 12 at 2:54 PM
	Health Care Sector Update for 05/12/2022: ABC, WBA, VERU, SHCR, XLV, IBB - Nasdaq nasdaq.com - May 12 at 9:53 AM
	Veru Q2 2022 Earnings Preview (NASDAQ:VERU) - Seeking Alpha seekingalpha.com - May 11 at 7:25 PM
	Veru stock soars after FDA agrees COVID-19 treatment can be submitted for EUA application - MarketWatch marketwatch.com - May 11 at 7:25 PM
	Veru shares are trading higher after the company announced that in a Pre-EUA meeting, the FDA said the co - Benzinga benzinga.com - May 11 at 2:20 PM

	Why Veru Shares Are Soaring Today Premarket finance.yahoo.com - May 11 at 2:20 PM
	FDA States that Veru Should Submit Request for Emergency Use Authorization (EUA) Based on Positive Efficacy and Safety Data from the Phase 3 Clinical Study of Sabizabulin in Hospitalized COVID-19 Patients - Yahoo Finance finance.yahoo.com - May 11 at 8:34 AM
	FDA States that Veru Should Submit Request for Emergency Use Authorization (EUA) Based on Positive Efficacy and Safety Data from the Phase 3 Clinical Study of Sabizabulin in Hospitalized COVID-19 Patients finance.yahoo.com - May 11 at 8:34 AM
	Veru stock soars after FDA agrees COVID-19 treatment can be submitted for EUA application finance.yahoo.com - May 11 at 8:34 AM
	The Week Ahead In Biotech (May 8-14): Bausch Health Headlines Smid-Cap Earnings, Veru's Pre-EUA Meeting, - Benzinga benzinga.com - May 9 at 2:55 PM
	Veru Stock Could Face Difficulties If the Culper Research Report Is True - InvestorPlace investorplace.com - May 9 at 2:55 PM
	Veru Stock Could Face Difficulties If the Culper Research Report Is True investorplace.com - May 9 at 10:02 AM
	Veru Inc. (VERU) Stock Moves -1.8%: What You Should Know finance.yahoo.com - May 5 at 11:54 PM
	Earnings Preview: Veru Inc. (VERU) Q2 Earnings Expected to Decline finance.yahoo.com - May 5 at 6:54 PM
	BioMed Momentum: NMLSF, BBI, LMLLF, VERU; Life Sciences Leaders Report Latest Advances in New Drug Development for Autism, COVID-19, Oncology, and Glaucoma - Yahoo Finance finance.yahoo.com - May 4 at 8:47 PM
	BioMed Momentum: NMLSF, BBI, LMLLF, VERU; Life Sciences Leaders Report Latest Advances in New Drug Development for Autism, COVID-19, Oncology, and Glaucoma - GlobeNewswire globenewswire.com - May 4 at 3:47 PM
	FDA Has Granted Veru a Pre-Emergency Use Authorization (EUA) Meeting Date for Positive Sabizabulin Phase 3 COVID-19 Study - Yahoo Finance finance.yahoo.com - May 2 at 7:59 PM
	Why Veru Stock Plummeted on Monday - The Motley Fool fool.com - May 2 at 7:59 PM
	Why Veru Stock Plummeted on Monday finance.yahoo.com - May 2 at 7:59 PM
	Veru gains after FDA grants pre-emergency use nod meeting date for COVID drug sabizabulin - Seeking Alpha seekingalpha.com - May 2 at 9:40 AM
	FDA Has Granted Veru a Pre-Emergency Use Authorization (EUA) Meeting Date for Positive Sabizabulin Phase 3 COVID-19 Study - GlobeNewswire globenewswire.com - May 2 at 9:40 AM
	FDA Has Granted Veru a Pre-Emergency Use Authorization (EUA) Meeting Date for Positive Sabizabulin Phase 3 COVID-19 Study finance.yahoo.com - May 2 at 9:40 AM
	Veru to Report Fiscal 2022 Second-Quarter Financial Results, Host Conference Call on May 12th - Yahoo Finance finance.yahoo.com - April 29 at 1:21 AM

Get Veru News Delivered to You Automatically

This page was last updated on 5/21/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources